Table 2: Cumulative incidence rate of chronic diseases in the ATP cohort (up to March 2018)*.
N=52,770 | Women (n = 33,627) | Men (n = 19,143) | Total (n = 52,770) | ||||||
Freq. | Person- year (PY) | Rate (per 1,000 PY) | Freq. | Person- year (PY) | Rate (per 1,000 PY) | Freq. | Person- year (PY) | Rate (per 1,000 PY) | |
Diabetes† | 1,546 | 304328.8 | 5.1 | 1,416 | 174966.0 | 8.1 | 2,962 | 479294.8 | 6.2 |
Hypertension† | 4,805 | 244532.7 | 19.6 | 3,664 | 138084.7 | 26.5 | 8,469 | 382617.4 | 22.1 |
Major CVD (total)**† | 3,714 | 287825.4 | 12.9 | 3,021 | 160366.5 | 18.8 | 6,735 | 448191.9 | 15.0 |
Unstable angina† | 158 | 325038.1 | 0.5 | 283 | 190866.1 | 1.5 | 441 | 515904.2 | 0.9 |
Myocardial infarction† | 271 | 325356.7 | 0.8 | 455 | 190328.8 | 2.4 | 726 | 515685.5 | 1.4 |
Ischemic heart disease† | 3,202 | 292394.8 | 11.0 | 2,696 | 162672.5 | 16.6 | 5,898 | 455067.3 | 13.0 |
Heart Failure† | 822 | 319686.2 | 2.6 | 600 | 189008.0 | 3.2 | 1,422 | 508694.2 | 2.8 |
Transient ischemic attack† | 69 | 326888.1 | 0.2 | 76 | 194956.6 | 0.4 | 145 | 521844.7 | 0.3 |
Acute ischemic stroke† | 161 | 326425.3 | 0.5 | 153 | 194418.4 | 0.8 | 314 | 520843.7 | 0.6 |
Chronic Obstructive Pulmonary Disease† | 980 | 320779.6 | 3.1 | 717 | 190559.2 | 3.8 | 1,697 | 511338.8 | 3.3 |
Asthma† | 1,259 | 308853.8 | 4.1 | 523 | 188143.5 | 2.8 | 1,782 | 496997.3 | 3.6 |
Obstructive Sleep Apnea | 1,842 | 310747.1 | 5.9 | 959 | 185235.9 | 5.2 | 2,801 | 495983.0 | 5.6 |
Osteoarthritis† | 4,740 | 271614.5 | 17.4 | 2,369 | 167789.0 | 14.1 | 7,109 | 439403.5 | 16.2 |
Osteoporosis† | 1,982 | 297184.4 | 6.7 | 165 | 193970.1 | 0.9 | 2,147 | 491154.4 | 4.4 |
Hypothyroidism | 2,925 | 284010.8 | 10.3 | 733 | 187554.8 | 3.9 | 3,658 | 471565.6 | 7.8 |
Chronic pain**† | 10,932 | 296263.2 | 36.9 | 5,152 | 179776.9 | 28.7 | 16,084 | 476040.1 | 33.8 |
(episodes) | (episodes) | (episodes) | |||||||
Depression**† | 50,132 | 298805.3 | 167.8 | 14,257 | 184720.8 | 77.2 | 64,389 | 483526.1 | 133.2 |
(episodes) | (episodes) | (episodes) |
*Cases were identified as “incident” only if the diagnosis date was >6 months after enrollment (clearance time, 2 years for depression and chronic pain) AND not in the first year when Alberta Health data was linked (washout time, 2 years for depression and chronic pain); person-years were calculated for a period between 6 months after enrollment and the date of diagnosis (or March 31, 2018, the end of data linkage).
**For major cardiovascular diseases (CVD), in addition to “clearance time” and “washout time”, cases with surgery (PCI or CABG) for major CVD or diagnosis with CVD before enrollment or within 6 months of enrollment were not considered as incident cases.
†there are statistically significant differences (p < 0.001) between women and men.